|
|
|
|
Regulatory evolution over the past 25 years has emphasized the development of age-appropriate formulations for pediatrics. Patient centricity in product development is essential for these formulations to succeed. This involves recognizing and addressing the physiological, psychological, and socioeconomic needs of both individual patients and larger pediatric populations within therapy design.
|
|
|
|
|
For orally delivered medicines, developers often must balance a drug’s “curb appeal” — its specific delivery mechanism, taste, ease of administration, and convenience — with safety and efficacy.
|
|
|
|
|
In the past, 3D-printed pharmaceuticals were largely relegated to niche markets and prototyping due to limited scalability and a reliance on manufacturing processes that could potentially damage active pharmaceutical ingredients. However, a new technology — 3D screen printing — is shattering preconceptions and opening new frontiers in drug formulation and manufacture.
|
|
|
|
|
Explore 3D screen printing’s potential to revolutionize pharmaceutical manufacturing with scalable, customizable, multi-drug tablets and precise, patient-centric drug release profiles.
|
|
|
|
|
|
|
Join Dr. Srinivasan Shanmugam in this webinar to learn key strategies for selecting the right CDMO, reducing costs, accelerating timelines, and ensuring product success.
|
|
|
